Analyst Ratings For Cryolife (NYSE:CRY)
Today, Canaccord Genuity reiterated its Buy rating on Cryolife (NYSE:CRY) with a price target of $28.00.
Some recent analyst ratings include
- 3/9/2018-Canaccord Genuity Reiterated Rating of Buy.
- 3/8/2018-Northland Securities Reiterated Rating of Buy.
- 2/17/2017-Ladenburg Thalmann Financial Services Upgrade from a “Neutral ” rating to a ” Buy” rating.
- 7/27/2016-Piper Jaffray Companies Reiterated Rating of Overweight.
Dividend information for Cryolife (NYSE:CRY)
and an average dividend growth of 0.00% based on a 3 Year Average..
Recent Insider Trading Activity For Cryolife (NYSE:CRY)
Cryolife (NYSE:CRY) has insider ownership of 6.00% and institutional ownership of 73.99%.
- On 12/15/2017 C Elkins Ronald, Director, sold 1,000 with an average share price of $20.00 per share and the total transaction amounting to $20,000.00.
- On 11/16/2017 David C Gale, VP, sold 20,000 with an average share price of $19.63 per share and the total transaction amounting to $392,600.00.
- On 11/8/2017 Amy Horton, CAO, sold 4,000 with an average share price of $19.00 per share and the total transaction amounting to $76,000.00.
- On 11/8/2017 David Ashley Lee, CFO, sold 33,190 with an average share price of $19.00 per share and the total transaction amounting to $630,610.00.
- On 11/6/2017 C Elkins Ronald, Director, sold 1,000 with an average share price of $19.03 per share and the total transaction amounting to $19,030.00.
- On 10/2/2017 James Benson, Director, sold 2,000 with an average share price of $22.80 per share and the total transaction amounting to $45,600.00.
- On 9/6/2017 James P Mackin, CEO, sold 125,000 with an average share price of $22.01 per share and the total transaction amounting to $2,751,250.00.
Recent Trading Activity for Cryolife (NYSE:CRY)
Shares of Cryolife closed the previous trading session at 22.60 up +0.50 2.26% with 22.299999237060547 shares trading hands.
